Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-317,594
Closed -$4.47M 4510
2026
Q1
$4.47M Buy
317,594
+85,929
+37% +$1.03M 0.01% 1072
2025
Q4
$2.13M Sell
231,665
-22,108
-9% -$192K 0.01% 1259
2025
Q3
$2.03M Buy
253,773
+147,758
+139% +$1.11M 0.01% 1142
2025
Q2
$1.02M Buy
106,015
+92,647
+693% +$855K ﹤0.01% 1260
2025
Q1
$117K Buy
+13,368
New +$112K ﹤0.01% 2127
2024
Q4
Sell
-266,660
Closed -$2.11M 2602
2024
Q3
$2.11M Buy
266,660
+130,781
+96% +$1.14M 0.01% 866
2024
Q2
$1.21M Sell
135,879
-8,312
-6% -$79.5K 0.01% 932
2024
Q1
$1.68M Buy
+144,191
New +$1.45M 0.01% 653
2023
Q2
Sell
-97,661
Closed -$1.36M 2654
2023
Q1
$1.36M Buy
+97,661
New +$1.4M 0.02% 800
2022
Q4
Sell
-81,970
Closed -$1.15M 2625
2022
Q3
$1.15M Buy
+81,970
New +$1.33M 0.01% 833

Other funds holding EHAB

HRT Financial's EHAB Position: Q2 2026 in Review

HRT Financial sold out of Enhabit (EHAB) in Q2 2026, closing a stake of 317,594 shares — an estimated $4.47M sold.

HRT Financial first reported a position in EHAB in Q3 2022 and held it in 10 quarters. The position peaked at $4.47M in Q1 2026. 1 fund tracked by Wall St. Rank holds EHAB as of Q2 2026.

  • HRT Financial reported no remaining Enhabit position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 317,594 Enhabit shares in Q2 2026, an estimated $4.47M.
  • HRT Financial first reported a position in Enhabit in Q3 2022 and held it in 10 quarters.
  • HRT Financial's Enhabit position peaked at $4.47M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Enhabit as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.